Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: Massachusetts General Hospital
Condition: Renal Cell Carcinoma
NCT00556205
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Toxicity of combination from other trials